BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ritchie C, Okuro M, Kanbayashi T, Nishino S. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights. Curr Neurol Neurosci Rep 2010;10:180-9. [PMID: 20425033 DOI: 10.1007/s11910-010-0100-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ballotta D, Talami F, Pizza F, Vaudano AE, Benuzzi F, Plazzi G, Meletti S. Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1. Neuroimage Clin 2021;31:102748. [PMID: 34252875 DOI: 10.1016/j.nicl.2021.102748] [Reference Citation Analysis]
2 Zajo KN, Fadel JR, Burk JA. Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons. Psychopharmacology (Berl) 2016;233:639-47. [PMID: 26534765 DOI: 10.1007/s00213-015-4139-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
3 Beuckmann CT, Ueno T, Nakagawa M, Suzuki M, Akasofu S. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep 2019;42:zsz076. [PMID: 30923834 DOI: 10.1093/sleep/zsz076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Baykal S, Albayrak Y, Durankuş F, Güzel S, Abbak Ö, Potas N, Beyazyüz M, Karabekiroğlu K, Donma MM. Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder. Neurol Sci 2019;40:593-602. [DOI: 10.1007/s10072-018-3692-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
5 Kanbayashi T, Sagawa Y, Takemura F, Ito S, Tsutsui K, Hishikawa Y, Nishino S. The Pathophysiologic Basis of Secondary Narcolepsy and Hypersomnia. Curr Neurol Neurosci Rep 2011;11:235-41. [DOI: 10.1007/s11910-011-0178-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
6 Kotagal S, Chopra A. Pediatric Sleep-Wake Disorders. Neurologic Clinics 2012;30:1193-212. [DOI: 10.1016/j.ncl.2012.08.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ono H, Kanbayashi T, Imanishi A, Ayabe T, Sagawa Y, Tsutsui K, Ohmori Y, Takeshima M, Nishino S, Shimizu T. Clinical characteristics of symptomatic narcolepsy or hypersomnia: an analysis of 182 consecutive cases with neurological disorders associated with hypersomnolence. Sleep Biol Rhythms 2019;17:123-40. [DOI: 10.1007/s41105-018-0186-2] [Reference Citation Analysis]
8 Holden JE. Putting the bio in biobehavioral: animal models. West J Nurs Res 2011;33:1017-29. [PMID: 21454886 DOI: 10.1177/0193945911403776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Vassalli A, Dellepiane JM, Emmenegger Y, Jimenez S, Vandi S, Plazzi G, Franken P, Tafti M. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children. Brain 2013;136:1592-608. [PMID: 23616586 DOI: 10.1093/brain/awt069] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
10 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 10.1] [Reference Citation Analysis]
11 Karimi S, Hamidi G, Fatahi Z, Haghparast A. Orexin 1 receptors in the anterior cingulate and orbitofrontal cortex regulate cost and benefit decision-making. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;89:227-35. [DOI: 10.1016/j.pnpbp.2018.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Xu TR, Ward RJ, Pediani JD, Milligan G. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation. J Biol Chem 2012;287:14937-49. [PMID: 22389503 DOI: 10.1074/jbc.M111.334300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Gao XB, Horvath TL. An arousing discovery on catalepsy: orexin regulates vestibular motor functions. Neuron 2011;69:588-90. [PMID: 21338870 DOI: 10.1016/j.neuron.2011.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Guo Y, Feng P. OX2R activation induces PKC-mediated ERK and CREB phosphorylation. Exp Cell Res 2012;318:2004-13. [PMID: 22652455 DOI: 10.1016/j.yexcr.2012.04.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]